ed and outstanding, respectively 53,431 50,797
Total stockholders' deficit (210,153) (18,037)
$2,236,373 $2,366,494
US ONCOLOGY HOLDINGS, INC.
RECONCILIATION OF NET INCOME (LOSS) AND SELECTED BALANCE SHEET DATA
(in thousands)
(unaudited)
Reconciliation of Holdings Net Loss to US Oncology Net Income (Loss):
Three Months Ended Year Ended
December 31, 2007 December 31, 2007
Holdings Net Loss $(14,830) $(34,973)
Add back: General and administrative expense (21) 97
Other (income) expense 11,573 11,885
Loss on extinguishment of debt - 12,917
Interest expense 12,765 42,154
Effective tax rate differential (9,185) (24,894)
US Oncology Net Income $302 $7,186
Reconciliation of Selected Balance Sheet Data:
December 31, 2007
Holdings
combining
entries and
US Oncology eliminations Holdings
Total assets $2,208,650 $27,723 $2,236,373
Total liabilities 1,641,110 430,594 2,071,704
Preferred stock - 361,605 361,605
Stockholders' equity (deficit) 554,323 (764,476) (210,153)
US ONCOLOGY HOLDINGS, INC.
'/>"/>
SOURCE US Oncology Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Related biology technology :1.
Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network2.
Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit3.
Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)4.
Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology5.
Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China6.
PRA International to Present Audioconference on Oncology Research - Nov. 87.
IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers8.
AG Mednet to Provide Image Network for Southwest Oncology Group9.
Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology10.
Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study11.
Oncology Metrics and Cureline Announce Joint Marketing Agreement